The Effects of Exenatide Once Weekly (EXQW) and Exenatide Twice a Day (EXBID) on Beta-Cell Function in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Diabetes Research"
DOI: 10.1155/2019/8083417
Abstract: Background In patients with type 2 diabetes mellitus (T2DM) and poor glycemic control receiving metformin (MET), glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are recommended as the adjunctive therapy. However, there are only a few studies… read more here.
Keywords: homa; network; type diabetes; meta ... See more keywords